tiprankstipranks
Cardiff Oncology, Inc. (DE:XE7C)
FRANKFURT:XE7C
Germany Market

Cardiff Oncology (XE7C) Income Statement

Compare
2 Followers

Cardiff Oncology Income Statement

Last quarter (Q3 2024), Cardiff Oncology's total revenue was $165.00K, an increase of 17.02% from the same quarter last year. In Q3, Cardiff Oncology's net income was $-11.86M. See Cardiff Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 488.00K$ 386.00K$ 359.00K$ 365.99K$ 245.00K
Gross Profit
$ 488.00K$ 186.00K$ -141.00K$ -10.87M$ -10.92M
Operating Expenses
$ 45.90M$ 40.29M$ 29.21M$ 19.45M$ 16.92M
Depreciation and Amortization
$ 398.00K$ 200.00K$ 500.00K$ 466.01K$ 494.23K
EBITDA
$ -45.01M$ -39.67M$ -28.40M$ -18.84M$ -15.92M
Operating Income
$ -45.41M$ -39.90M$ -28.86M$ -19.09M$ -16.68M
Other Income/Expenses
$ 3.97M$ 1.20M$ 564.00K$ -220.67K$ 264.33K
Pretax Income
$ -41.44M$ -38.70M$ -28.29M$ -19.31M$ -16.41M
Net Income
$ -41.44M$ -37.51M$ -27.74M$ -19.28M$ -16.15M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.93$ -0.86$ -0.71$ -0.92$ -2.70
Diluted EPS
$ -0.93$ -0.86$ -0.71$ -0.92$ -2.70
Weighted Average Shares Outstanding
44.68M 43.60M 39.03M 20.87M 5.97M
Weighted Average Shares Outstanding (Diluted)
44.68M 43.60M 39.03M 20.87M 5.97M
Currency in USD

Cardiff Oncology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis